Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EBT (2016 - 2025)

Orthopediatrics (KIDS) has disclosed EBT for 10 consecutive years, with -$9.8 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 40.5% to -$9.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$39.2 million, a 6.54% increase, with the full-year FY2025 number at -$39.2 million, up 6.54% from a year prior.
  • EBT was -$9.8 million for Q4 2025 at Orthopediatrics, up from -$11.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $14.4 million in Q3 2022 to a low of -$16.4 million in Q4 2024.
  • A 5-year average of -$6.2 million and a median of -$7.2 million in 2023 define the central range for EBT.
  • Biggest YoY gain for EBT was 678.38% in 2022; the steepest drop was 4656.63% in 2022.
  • Orthopediatrics' EBT stood at -$166000.0 in 2021, then crashed by 4656.63% to -$7.9 million in 2022, then increased by 12.58% to -$6.9 million in 2023, then plummeted by 137.71% to -$16.4 million in 2024, then soared by 40.5% to -$9.8 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's EBT are -$9.8 million (Q4 2025), -$11.9 million (Q3 2025), and -$7.1 million (Q2 2025).